Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06776432 · ClinicalTrials.gov registry record · Phase 2

Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

A Phase 2 study of Sleep Apnea, sponsored by Shionogi Apnimed Sleep Science.

Recruiting
Registry status
Phase 2
Development phase
60
Enrollment target
9
Study locations

NCT06776432 is a Phase 2 study of Sleep Apnea that is actively recruiting participants, run by Shionogi Apnimed Sleep Science. The registered enrollment target is 60 participants, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (98% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06776432, a Phase 2 study of Sleep Apnea, is actively recruiting participants, sponsored by Shionogi Apnimed Sleep Science.

RECRUITING
Registry status
Phase 2
Development phase
60 participants
Enrollment target
9
Study locations

Study Summary

The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.

Conditions Studied

Sleep Apnea

Interventions

  • DRUG Placebo
  • DRUG Acetazolamide
  • DRUG Sivopixant
  • DRUG SASS-001

Study Locations (9)

Florida

  • Teradan Clinical Trials - Brandon
  • PharmaDev Clinical Research Institute, LLC - Miami

California

  • Altman Clinical and Translational Research Institute (ACTRI) - La Jolla

Massachusetts

  • Infinity Medical Research - North Dartmouth

Michigan

  • John D. Dingell VA Medical Center - Detroit

Minnesota

  • Mayo Clinic - Rochester

Ohio

  • Intrepid Research, LLC - Cincinnati

South Carolina

  • OnSite Clinical Solutions - Rock Hill

Texas

  • Huntsville Research Institute LLC - Huntsville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-04-02
Est. Completion 2025-12
Phase Phase 2

Sponsor

Shionogi Apnimed Sleep Science

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06776432

The ClinicalTrials.gov registry entry for NCT06776432 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,988-participant average among 36 other Sleep Apnea trials with a reported enrollment target (98% lower). The listed sponsor is Shionogi Apnimed Sleep Science, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.

NCT06776432 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06776432 about?

NCT06776432 is a clinical study titled "Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea". The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a central component.

What is the current status of trial NCT06776432?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2025-04-02. Estimated completion is 2025-12.

What conditions does trial NCT06776432 study?

This clinical trial studies the following conditions: Sleep Apnea.

What interventions are being tested in trial NCT06776432?

The interventions under investigation include: Placebo (DRUG), Acetazolamide (DRUG), Sivopixant (DRUG), SASS-001 (DRUG).

Who is sponsoring clinical trial NCT06776432?

This trial is sponsored by Shionogi Apnimed Sleep Science, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06776432 being conducted?

This trial has 9 study locations across California, Florida, Massachusetts, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sleep Apnea

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.